Since it was possible to identify it, the respiratory syncytial virus is the second most prevalent at the moment after COVID-19.
According to the National Institute of Public Health, there were 715 cases of RSV last week, making it the second most prevalent virus after VCOVID 19 with 1,150 positive tests.
This virus is mainly present in infants and the elderly and can cause serious respiratory tract infections requiring hospitalization.
In Gaspésie, few tests have been carried out and no cases have been declared at this time.
According to pulmonologist, Dr. Dominique Deschênes, before the COVID-19 pandemic it was impossible to identify RSV.
Thanks to this advance, it is now obvious that the respiratory syncytial virus is more present than we imagined;
Dr. Dominique Deschênes explains the benefits of identifying RSV, even if today there is no drug to cure it:
In the meantime, a vaccine is available in Quebec this fall and free according to certain criteria.
Health
